| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Financial Officer | Senior Vice President, Finance
2 companies
Goddard Glenn is an EVP, Chief Financial Officer at Intellia Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 20 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2024 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Financial Officer | Sell | 5,365 | $29.46 | $158,052.90 | -11.7% | -14.9% | -58.6% | |
| Jan 4, 2023 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Financial Officer | Sell | 2,427 | $37.21 | $90,308.67 | -13.6% | -7.5% | -24.6% | |
| Jan 1, 2022 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Financial Officer | Sale+OE | 1,013 | $112.24 | $113,699.12 | -33.1% | -35.6% | -70.7% | |
| Sep 7, 2021 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Financial Officer | Sale+OE | 3,482 | $180.12 | $627,177.84 | -100% | -38.3% | -64.7% | |
| Aug 31, 2021 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Financial Officer | Sale+OE | 30,000 | $159.45 | $4,783,537.56 | -70.1% | -30.4% | -62.6% | |
| Aug 5, 2021 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Financial Officer | Sale+OE | 20,000 | $151.05 | $3,021,056.08 | -65.3% | -17.7% | -61.7% | |
| Sep 24, 2015 | AGIO Agios Pharmaceuticals, Inc. | Senior Vice President, Finance | Sale+OE | 6,000 | $85.97 | $515,820.00 | -100% | - | - | |
| Jul 23, 2015 | AGIO Agios Pharmaceuticals, Inc. | Senior Vice President, Finance | Sale+OE | 7,000 | $120.45 | $843,150.00 | -100% | - | - | |
| Jul 17, 2015 | AGIO Agios Pharmaceuticals, Inc. | Senior Vice President, Finance | Sale+OE | 13,000 | $113.71 | $1,478,230.00 | -100% | - | - | |
| May 27, 2015 | AGIO Agios Pharmaceuticals, Inc. | Senior Vice President, Finance | Sale+OE | 2,171 | $120.05 | $260,628.55 | -100% | - | - |